Home › NDC Lookup › RxCUI directory › RxCUI 2637032

24 HR lacosamide 200 MG Extended Release Oral Capsule — RxCUI 2637032

RxNorm drug concept · Semantic clinical drug
RxCUI 2637032 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2637032
Official name24 HR lacosamide 200 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslacosamide 200 MG 24HR Extended Release Oral Capsule
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,180 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lacosamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lacosamide is used to treat seizures — specifically partial-onset seizures, which start in one part of the brain, in adults and children. It's also approved as an add-on treatment...
  • Yes — dizziness is the most commonly reported side effect of lacosamide, and it's most likely to happen during the early weeks when your dose is being increased. It usually gets be...
  • Is it normal to feel dizzy when I start this medication?
  • Please don't stop suddenly. Stopping lacosamide abruptly can cause a sudden increase in seizures, which can be dangerous. If you're having side effects or want to stop, talk to you...
📖 Read our full Lacosamide guide →

🕸️ Concept Web — How 24 HR lacosamide 200 MG Extended Release Oral Ca... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR lacosamide 200 MG Extended Release Oral Capsule RxCUI 2637032

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lacosamide 623400
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Motpoly 2637020
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lacosamide Extended Release Oral Capsule 2637017
    • Lacosamide Oral Product 1162529
    • Lacosamide Pill 1162530
    • Lacosamide Extended Release Oral Capsule [Motpoly] 2637024
    • Motpoly Oral Product 2637022
    • Motpoly Pill 2637023
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lacosamide 200 MG SCDC · 809995
  • Lacosamide Extended Release Oral Capsule SCDF · 2637017
  • Lacosamide Oral Product SCDG · 1162529
  • Lacosamide Pill SCDG · 1162530

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2637032 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
73289-0063-01 1 BLISTER PACK in 1 CARTON (73289-0063-1) / 14 CAPSULE, EXT... MOTPOLY XR Aucta Pharmaceuticals, Inc. 2023-05-05
73289-0063-02 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-006... MOTPOLY XR Aucta Pharmaceuticals, Inc. 2023-05-05
73289-0064-02 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-006... MOTPOLY XR Aucta Pharmaceuticals, Inc. 2023-05-05
73289-0065-02 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-006... MOTPOLY XR Aucta Pharmaceuticals, Inc. 2023-05-05
Observed labelers: Aucta Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.